ClinConnect ClinConnect Logo
Search / Trial NCT06432517

Sources and Mechanisms of Energy Compensation

Launched by SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY ,CHINESE ACADEMY OF SCIENCES · May 21, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Energy Compensation Energy Balance Food Preferences

ClinConnect Summary

This clinical trial is studying how exercise affects energy use and food choices in young adult men. Researchers want to find out if doing moderate to high-intensity exercise changes how much energy the body burns at rest (basal energy expenditure) and what types of food participants prefer to eat afterward. To do this, they will have participants undergo body composition tests and then either exercise for 30 minutes or not after a light breakfast. Throughout the study, researchers will measure how much food participants eat, their feelings of hunger, and various metabolic markers through blood tests.

To participate in this study, you must be a healthy male between the ages of 18 and 40, with a body mass index (BMI) of at least 18.5. However, individuals with certain health conditions, recent surgeries, or those taking long-term medications are not eligible. Participants can expect to spend some time at the lab, undergoing tests and exercises, and will receive insight into how exercise might influence their energy use and food preferences. This research could help us understand better ways to manage energy balance and obesity.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Healthy adults (men)
  • 18-40 years old
  • BMI (body mass index)≥18.5 kg/m2
  • Exclusion Criteria:
  • Those who have undergone surgery in the past 6 months.
  • People are requiring long-term medication.
  • People have metabolic diseases, like diabetes, hypoglycemia, gout, osteoporosis, et al.
  • People have digestive diseases, like gastric ulcer, pancreatitis, Intestinal obstruction, et al.
  • People have sports injury, like fracture, Joint injury, et al.
  • Those who have recently lost weight for various medical reasons (e.g. cancer, etc.).
  • People are losing weight by tablets.
  • People are suffering from infectious diseases (e.g. HIV, etc.)
  • People have blood phobia, pathological hypo or hyper tension.
  • People with impaired glucose tolerance.
  • Those who are afflicted with claustrophobia.

About Shenzhen Institutes Of Advanced Technology ,Chinese Academy Of Sciences

The Shenzhen Institutes of Advanced Technology (SIAT), part of the Chinese Academy of Sciences, is a leading research institution dedicated to advancing scientific knowledge and technology across various fields, including biomedical research. SIAT is committed to fostering innovation through interdisciplinary collaboration and state-of-the-art facilities, focusing on the translation of research into practical applications. With a strong emphasis on clinical trials and regulatory compliance, SIAT aims to contribute to the global healthcare landscape by developing novel therapies and solutions that address pressing medical challenges.

Locations

Shenzhen, Guangdong, China

Patients applied

0 patients applied

Trial Officials

John Speakman

Study Chair

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported